Muscular Dystrophy, Duchenne Type

- Cell Therapy Approaches

Duchenne muscular dystrophy is caused by a mutation in the DMD gene, which encodes dystrophin, an important structural component of muscle tissue that provides structural stability to the dystroglycan complex (DGC) of the cell membrane.

Cell Therapy Approaches

Cell therapy utilizing different stem cells have the potential to fuse with human myoblasts and to restore dystrophin expression.

This site does not provide medical advice and is for research use only

Welcome to
LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Muscular Dystrophy, Duchenne Type

- Cell Therapy Approaches

Cell Therapy Approaches

Cell Therapies for the treatment of

Modeling of

Affected or Therapy-targeted Cells/Compartments for

Literature related to

Welcome to LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Muscular Dystrophy, Duchenne Type - Cell Therapy Approaches

Cell Therapy Approaches

Cell Therapies for the treatment of

Modeling of

Affected or Therapy-targeted Cells/Compartments for

Literature related to

Welcome to
LifeMap Discovery

Muscular Dystrophy, Duchenne Type

- Cell Therapy Approaches